Filing metadata

Accession number
0000905148-24-000165
Form type
Form 3
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Jan 12, 2024
Reporting period
Jan 02, 2024
Description
Initial ownership

Explore SEC Filings Hub